Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EFCAB13 divergent transcript (EFCAB13-DT)
- Target
- EFCAB13-DT
- Molecular classification
- Other (Long non-coding RNA), Divergent transcript (non-coding, antisense, or bi-directional transcript)
01
Overview
EFCAB13 divergent transcript (EFCAB13-DT) is a long non-coding RNA annotated in genomic databases, described as a thyroid cancer-associated transcript on the basis of transcriptomic profiling. It does not encode a functional protein and is not considered a canonical therapeutic target. The molecular function and biological role are unclear, and there are no established drug interactions or mechanisms of action. Although it may be transcriptionally upregulated in certain thyroid cancers, there is currently no evidence supporting use as a biomarker or drug target, and very little has been published regarding its direct involvement in cancer biology or therapeutic modulation.
- Other names
- THCAT158Thyroid cancer-associated transcript 158MRPL45P2EFCAB13-DT
02
Biological functions
Other (Unclear; may regulate nearby EFCAB13 gene, but no definitive function described in the literature)
03
Disease associations
Cancer (Transcriptomics association only, specifically thyroid cancer)
Beyond the preview
Go deeper on EFCAB13 divergent transcript (EFCAB13-DT).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EFCAB13 divergent transcript (EFCAB13-DT).